Evidence-Based Medical News

Mode

All Oncology Infectious Disease Neurology Psychiatry Cardiology Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Anesthesiology & Pain Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Emergency Medicine Urology Ophthalmology Hematology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

fluoxetine

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of fluoxetine

52 trials tracked of fluoxetine: 24 in phase 3 or 4 and 9 with published results. The most-cited published study has 449 citations.

52Trials tracked

24Phase 3 & 4

0Recruiting

9With published results

Phase distribution

Phase 4 12 Phase 3 12 Phase 2 16 Phase 1 3 Other / NA 9

Phase 4 Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder Completed · 449 cited
Phase 4 Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa Completed · 393 cited
Phase 4 Improving Sleep and Psychological Functioning in People With Depression and Insomnia Completed · 240 cited
Phase 4 Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder Completed · 126 cited
Phase 3 Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) Completed · 13 cited
Phase 4 Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging Completed · 8 cited

Show 44 more trials

Phase 4 Identifying and Treating Depression in Hemodialysis Patients Completed · 7 cited
Phase 3 Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder Completed · 6 cited
Phase 3 Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder Completed · 6 cited
Phase 4 The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder Completed
Phase 4 Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning Completed
Phase 4 Fluoxetine to Reduce Intubation and Death After COVID19 Infection Completed
Phase 4 Fluoxetine Treatment of Depression in Down Syndrome Completed
Phase 4 A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression Completed
Phase 4 Fluoxetine in Pediatric Body Dysmorphic Disorder Completed
Phase 3 Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms Completed
Phase 3 Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Completed
Phase 3 A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing Completed
Phase 3 A Study in the Treatment of Children and Adolescents With Major Depressive Disorder Completed
Phase 3 A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing Completed
Phase 3 A Study in Relapse Prevention of Treatment-Resistant Depression Completed
Phase 3 A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD Completed
Phase 3 Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia Completed
Phase 3 A Study in the Treatment of Children and Adolescents With Major Depressive Disorder Completed
Phase 2 Poststroke Depression in Hemorrhagic Stroke Completed
Phase 2 Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence Completed
Phase 2 An Adaptive Treatment Strategy for Adolescent Depression-Continuation Completed
Phase 2 Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation Completed
Phase 2 Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI Completed
Phase 2 Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression Completed
Phase 2 An Adaptive Treatment Strategy for Adolescent Depression Completed
Phase 2 Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma Completed
Phase 2 Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial Completed
Phase 2 Early Intervention With Fluoxetine in Autism Completed
Phase 2 Homeopathic Treatment for Depression in Peri- and Postmenopausal Women Completed
Phase 2 A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder Completed
Phase 2 Dichotic Listening as a Predictor of Medication Response in Depression Completed
Phase 2 Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients Completed
Phase 2 Treatment of Hypochondriasis With CBT and/or SSRI Completed
Phase 2 Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension Completed
Phase 1 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions Completed
Phase 1 90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions Completed
Phase 1 A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together. Completed
N/A A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Completed
N/A Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women Completed
N/A Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy Completed
N/A SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project Completed
N/A Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea Completed
N/A Brain Imaging Techniques That Predict Antidepressant Responsiveness Completed
N/A Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse Completed

Showing the 50 most-cited and recently-updated of 52 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.